Home / Business and Economy / Roche Embraces AI for Faster Drug Discovery

Roche Embraces AI for Faster Drug Discovery

28 Sep

Summary

Roche is building autonomous AI-driven laboratories.
The goal is to accelerate research and development.
The company aims for "AI independence" in its R&D.

Swiss pharmaceutical giant Roche announced on Monday its strategic pivot towards fully autonomous AI laboratories. This initiative is designed to significantly expedite the discovery phase of its research and development efforts.

Aviv Regev, executive vice president of Genentech Research and Early Development, revealed that Roche has begun constructing these advanced AI-driven labs. The company is deeply committed to achieving complete "AI independence" in its R&D activities, signaling a future where artificial intelligence plays a central, self-sufficient role in scientific exploration and drug creation.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.